Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Affiliations

¹ Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy.
² Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Editorial

Pier Luigi Meroni et al. Front Immunol. 2019.

. 2019 Feb 25:10:199.

doi: 10.3389/fimmu.2019.00199. eCollection 2019.

¹ Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy.
² Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

No abstract available

Keywords: T cell; anti-phospholipid yindrome; autoantibodies; complement; systemic lupus erythematosus.

Comment on

Editorial on the Research Topic Systemic Lupus Erythematosus and Antiphospholipid Syndrome

1. Tincani A, Andreoli L, Chighizola C, Meroni PL. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity (2009) 42:257–9. 10.1080/08916930902827918 - DOI - PubMed
1. Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, et al. . Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? J Autoimmun. (2008) 30:51–7. 10.1016/j.jaut.2007.11.004 - DOI - PubMed
1. Yin H, Borghi MO, Delgado-Vega AM, Tincani A, Meroni PL, Alarcón-Riquelme ME. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome. Arthritis Rheum. (2009) 60:2468–71. 10.1002/art.24701 - DOI - PubMed
1. Fredi M, Tincani A, Yin H, Delgado-Vega AM, Borghi MO, Meroni PL, et al. IRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factor. Arthritis Rheum. (2010) 62:1201–2. 10.1002/art.27345 - DOI - PubMed
1. Wallace DJ. The evolution of drug discovery in systemic lupus erythematosus. Nat Rev Rheumatol. (2015) 11:616. 10.1038/nrrheum.2015.86 - DOI - PubMed